Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4086405
Max Phase: Preclinical
Molecular Formula: C36H43N7O5S
Molecular Weight: 685.85
Molecule Type: Small molecule
Associated Items:
ID: ALA4086405
Max Phase: Preclinical
Molecular Formula: C36H43N7O5S
Molecular Weight: 685.85
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: C[C@H](O)[C@H](NC(=O)[C@H](CCc1ccccc1)NC(=O)CCc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)c1nc2ccccc2s1
Standard InChI: InChI=1S/C36H43N7O5S/c1-23(44)31(34(48)41-27(16-10-22-39-36(37)38)32(46)35-42-26-15-8-9-17-29(26)49-35)43-33(47)28(20-18-24-11-4-2-5-12-24)40-30(45)21-19-25-13-6-3-7-14-25/h2-9,11-15,17,23,27-28,31,44H,10,16,18-22H2,1H3,(H,40,45)(H,41,48)(H,43,47)(H4,37,38,39)/t23-,27-,28-,31-/m0/s1
Standard InChI Key: DPQVXMOIEVMPBL-RONPGKLQSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 685.85 | Molecular Weight (Monoisotopic): 685.3046 | AlogP: 2.84 | #Rotatable Bonds: 18 |
Polar Surface Area: 199.39 | Molecular Species: BASE | HBA: 8 | HBD: 7 |
#RO5 Violations: 2 | HBA (Lipinski): 12 | HBD (Lipinski): 8 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 11.67 | CX Basic pKa: 11.46 | CX LogP: 2.76 | CX LogD: 0.87 |
Aromatic Rings: 4 | Heavy Atoms: 49 | QED Weighted: 0.04 | Np Likeness Score: -0.21 |
1. St-Georges C, Désilets A, Béliveau F, Ghinet M, Dion SP, Colombo É, Boudreault PL, Najmanovich RJ, Leduc R, Marsault É.. (2017) Modulating the selectivity of matriptase-2 inhibitors with unnatural amino acids., 129 [PMID:28219045] [10.1016/j.ejmech.2017.02.006] |
Source(1):